Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07435077 · ClinicalTrials.gov registry record · Phase 4
Examining Analgesic Synergy and Efficacy in Trauma Care
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- Phase 4
- Development phase
- 282
- Enrollment target
NCT07435077 is a Phase 4 study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 282 participants.
The verdict
NCT07435077, a Phase 4 study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 282 participants
- Enrollment target
Study Summary
Traumatic injury is responsible for over 25 million (16%) Emergency Department visits and over 225,000 deaths each year per 2021 Center for Disease Control data. This is the 3rd leading cause of death in the US. Often, acute care for the injured patient requires administration of pain medication for the purposes of acute pain control from injury. The mainstay of treatment for pain control has historically involved opioid pain medication.
Interventions
- DRUG Oxycodone
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2026-08 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07435077
The ClinicalTrials.gov registry entry for NCT07435077 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxycodone is the first listed.
NCT07435077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07435077 about?
NCT07435077 is a clinical study titled "Examining Analgesic Synergy and Efficacy in Trauma Care". Traumatic injury is responsible for over 25 million (16%) Emergency Department visits and over 225,000 deaths each year per 2021 Center for Disease Control data. This is the 3rd leading cause of death in the US. Often, acute care for the injured patient requires administration of pain medication for...
What is the current status of trial NCT07435077?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 282 participants. The study started on 2026-08. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07435077?
The interventions under investigation include: Oxycodone (DRUG), Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT07435077?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.